TG Therapeutics's market cap is currently $5.14B. The company's EPS TTM is $0.17; its P/E ratio is 86.50; TG Therapeutics is scheduled to report earnings on August 4, 2025, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.
